Leukemia Clinical Trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 22 clinical trials
None
High Dose Steroids in Children With Stroke

This clinical trial deals with focal cerebral arteriopathy and childhood stroke, a rare but devastating condition. Focal cerebral arteriopathy (FCA) is an inflammatory vessel wall disease provoked by infection and there is increasing evidence that inflammatory processes play a crucial role in childhood stroke, influencing the outcome of the disease. …

  • 0 views
  • 02 Dec, 2021
  • 1 location
None
Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures

To assess the efficacy of intravenous remimazolam in inducing and maintaining suitable sedation levels for paediatric patients undergoing diagnostic and/or therapeutic procedures

  • 0 views
  • 02 Dec, 2021
  • 1 location
None
Tegavivint for the Treatment of Relapsed or Refractory Leukemia

This phase I trial is to find out the best dose and side effects of tegavivint in treating patients with leukemia that has come back (relapsed) or does not response to treatment (refractory

  • 0 views
  • 03 Dec, 2021
  • 1 location
None
Decitabine Alone or in Combination With Venetoclax Gilteritinib Enasidenib or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission

acute myeloid leukemia that is under control (remission). Chemotherapy drugs, such as decitabine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them

decitabine
cancer
consolidation therapy
venetoclax
residual tumor
  • 0 views
  • 01 Dec, 2021
  • 1 location
None
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

patients with acute myeloid leukemia and high-grade myeloid neoplasms. Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Chemotherapy drugs, such

mitoxantrone
ejection fraction
cancer
blast cells
cladribine
  • 0 views
  • 05 Dec, 2021
  • 1 location
None
A Safety Tolerability Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL.

This is a Phase 1/2 study of GB261 in participants with relapsed or refractory B-cell NHL and CLL. The study will consist of a dose-escalation stage(Phase 1), an expansion stage(Phase 2a) and Phase 2b stage where participants will be enrolled into indication-specific cohorts.

lymphoma
  • 0 views
  • 28 Nov, 2021
  • 1 location
None
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Chronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries, representing approximately 30% of all adult leukemias. There is a large difference in proportion of malignant

lymphoma
ibrutinib
venetoclax
chronic lymphocytic leukemia
obinutuzumab
  • 0 views
  • 05 Dec, 2021
  • 20 locations
None
Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)

The proposal is to conduct a prospective, multi-cohort study aiming to decipher molecular profiles/biological characteristics of advanced cancer patients during the course of their disease with longitudinal and sequential analyses of tumor and liquid biopsies. This approach will allow i) to develop a model in order to predict tumor response …

cancer treatment
BRAF
RET
cancer
chronic lymphocytic leukemia
  • 0 views
  • 25 Nov, 2021
  • 2 locations
None
Selenious Yeast in CLL Patients w/o Indication of Chemotherapy

The purpose of this study is to evaluate the safety and effectiveness of Selenious Yeast Tablets in Chronic Lymphocytic Leukemia Patients without Indication of Chemotherapy

  • 0 views
  • 05 Dec, 2021
  • 1 location
None
Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy

This study will evaluate the use of siltuximab to decrease the severity of cytokine release syndrome (CRS) and immune effector cell-associated neurological syndrome (ICANS) in patients who will receive chimeric antigen receptor (CAR) T-cell therapy for the treatment of hematological malignancies.

follicular lymphoma
leukemia
neutrophil count
diffuse large b-cell lymphoma
lymphoma
  • 0 views
  • 05 Dec, 2021
  • 1 location